Social Stress, Adiposity, and Breast Cancer

Information

  • Research Project
  • 10379021
  • ApplicationId
    10379021
  • Core Project Number
    R01CA253302
  • Full Project Number
    3R01CA253302-02S1
  • Serial Number
    253302
  • FOA Number
    PA-21-071
  • Sub Project Id
  • Project Start Date
    8/2/2020 - 3 years ago
  • Project End Date
    6/30/2023 - 10 months ago
  • Program Officer Name
    SAUTER, EDWARD RICHARD
  • Budget Start Date
    8/1/2021 - 2 years ago
  • Budget End Date
    6/30/2022 - a year ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
    S1
  • Award Notice Date
    9/17/2021 - 2 years ago
Organizations

Social Stress, Adiposity, and Breast Cancer

Project Summary Breast cancer persists as being the leading form of cancer among women in the United States (U.S.) with 1 in 8 women receiving the diagnosis in their lifetime. Body composition, notably visceral adipose tissue (VAT), is both a salient risk factor and prognostic indicator for breast cancer in post-menopausal women. Less is known about the role of subcutaneous adipose tissue (SAT) in breast cancer in this population. Accumulation of VAT coupled with menopause drives a pathophysiology of inflammatory, metabolic, and immunological dysfunction, measured by blood biomarkers, which are associated with cancer genesis. The role of social stress in the development of VAT is well established in the cardiometabolic literature. Yet, there is a paucity of literature on the intersection of social stress, body composition, and breast cancer. The specific aims of this Diversity Supplement are designed to address this critical gap in the breast cancer and body composition literature. These aims will: 1. Examine the relationship of social stress, adiposity types (VAT vs. SAT), and breast cancer incidence and mortality; 2. Examine the relationship of blood biomarkers and social stress to explore cancer promoting mechanisms of stress in post-menopausal women; 3. Provide training and professional development opportunities to Dr. Valencia, an underrepresented minority early-stage investigator. Through participation in the proposed research and training activities, Dr. Valencia will gain fundamental expertise in body composition, cancer promoting pathophysiological pathways, and social stress to help her achieve her ultimate career goals to continue to perform impactful cancer research.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R01
  • Administering IC
    CA
  • Application Type
    3
  • Direct Cost Amount
    114800
  • Indirect Cost Amount
    61418
  • Total Cost
    176218
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    393
  • Ed Inst. Type
    EARTH SCIENCES/RESOURCES
  • Funding ICs
    NCI:176218\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    CHSA
  • Study Section Name
    Cancer, Heart, and Sleep Epidemiology A Study Section
  • Organization Name
    UNIVERSITY OF ARIZONA
  • Organization Department
    NUTRITION
  • Organization DUNS
    806345617
  • Organization City
    TUCSON
  • Organization State
    AZ
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    857210158
  • Organization District
    UNITED STATES